Tat and HIV Transcription Initiation

Morris, Cindy Anne

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Institute of Allergy and Infectious Diseases (NIAID)
• Type: First Independent Research Support & Transition (FIRST) Awards (R29)
• Project #: 5R29AI032880-06
• Application #: 2067756
• Study Section: AIDS and Related Research Study Section 3 (ARRC)
• Project Start: 1992-07-01
• Project End: 1997-06-30
• Budget Start: 1996-07-01
• Budget End: 1997-06-30
• Support Year: 6
• Fiscal Year: 1996

Institution

• Name: Tulane University
• Department: Internal Medicine/Medicine
• Type: Schools of Medicine
• City: New Orleans
• State: LA
• Country: United States
• Zip Code: 70118

Publications

Wang, Z; Morris, G F; Reed, J C et al. (1999) Activation of Bcl-2 promoter-directed gene expression by the human immunodeficiency virus type-1 Tat protein. Virology 257:502-10

Yang, L; Morris, G F; Wang, Z et al. (1997) Repression of tumor necrosis factor-beta expression by the human immunodeficiency virus type-1 tat protein in central nervous system-derived glial cells. Virus Res 50:195-203

Yang, L; Morris, G F; Lockyer, J M et al. (1997) Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat. Virology 235:48-64

Tsang, S X; Morris, G F; Lu, M et al. (1996) TATA-dependent repression of human immunodeficiency virus type-1 transcription by the adenovirus E1A 243R oncoprotein. Oncogene 12:819-26

Morris, C B; Gendelman, R; Marrogi, A J et al. (1996) Immunihistochemical detection of Bcl-2 in AIDS-associated and classical Kaposi's sarcoma. Am J Pathol 148:1055-63